David Shaw’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-36,100
Closed -$2.34M – 5522
2021
Q3
$2.34M Buy
+36,100
New +$2.51M ﹤0.01% 2888
2020
Q2
– Sell
-20,000
Closed -$1.01M – 4095
2020
Q1
$1.01M Sell
20,000
-5,600
-22% -$372K ﹤0.01% 2721
2019
Q4
$1.9M Hold
25,600
– – ﹤0.01% 2518
2019
Q3
$1.46M Buy
+25,600
New +$1.7M ﹤0.01% 2589
2017
Q3
– Sell
-10,000
Closed -$498K – 3506
2017
Q2
$498K Sell
10,000
-200
-2% -$9.35K ﹤0.01% 2822
2017
Q1
$433K Buy
+10,200
New +$451K ﹤0.01% 2796

Other funds holding HQY

David Shaw's HQY Position: Q3 2026 in Review

David Shaw increased its HealthEquity (HQY) stake by 782% in Q3 2026, buying an estimated $15.7M and bringing the position to 180,292 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #1455.

David Shaw first reported a position in HQY in Q3 2014 and has held it in 22 quarters since. The position peaked at $31.1M in Q2 2019. 524 funds tracked by Wall St. Rank hold HQY as of Q3 2026.

  • David Shaw held 180,292 shares of HealthEquity worth $15.9M as of Q3 2026.
  • David Shaw bought 159,861 HealthEquity shares in Q3 2026, an estimated $15.7M.
  • HealthEquity made up 0.01% of David Shaw's portfolio in Q3 2026, its #1455 holding.
  • David Shaw first reported a position in HealthEquity in Q3 2014 and has held it in 22 quarters since.
  • David Shaw's HealthEquity position peaked at $31.1M in Q2 2019.
  • 524 funds tracked by Wall St. Rank held HealthEquity as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.